Revere Partners

Revere Partners is the first-ever venture capital fund focused on oral health—identifying opportunities for investors, providing capital for cutting-edge innovations in the oral and systemic health sectors. Revere is changing the landscape of dental and systemic health ventures, bringing market awareness, business acumen, and the top minds in the field together to elevate innovations and optimize both patient and provider experience. Revere is an AngelList Rolling Fund and can lead or follow, priced round or not, public or private. A strategic, active investor and thought leader, Revere provides the essential combination of dental industry expertise and analytical data research capabilities to predict trends and opportunities within the healthcare industry. Founders Jeremy Krell and David Arena have built an all-star 25+ person team to connect startups with leadership at the top dental chains, manufacturers, distributors, insurers, academics, professional associations, nationwide labs and retailers. With a mission to educate and create better outcomes, Revere conducted a 20-month research project leading to a first-of-its-kind, publishable paper proving the strong return profile of early-stage oral health investments. Revere’s data and track record also highlight the value of focusing on Seed and Series A rounds. In addition, the company has carved a space in their portfolio for small allotments to special opportunities such as pre-seed and innovation competitions, and follow-on investments (Series B and beyond). Investment targets include technology/diagnostics, dental services/biotech, consumer/brands, payments/reimbursement and access to care. Revere helps foster unrivaled strategic partnerships that will improve care delivery, as well as patient and providers experiences—maximizing value for investors.